Gene · 8434
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of the MicroRNAs in the Pathogenic Mechanism of Painful Symptoms in Long COVID: Systematic Review. | Int J Mol Sci | 2023 | 36834984 | PubTator, text mining | PubMed |
| Role of PI3K-AKT Pathway in Ultraviolet Ray and Hydrogen Peroxide-Induced Oxidative Damage and Its Repair by Grain Ferments. | Foods | 2023 | 36832881 | PubTator, text mining | PubMed |
| MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. | Cancers (Basel) | 2023 | 36831632 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. | Int J Mol Sci | 2023 | 36768732 | PubTator, text mining | PubMed |
| Cell-Cycle Dysregulation in the Pathogenesis of Diabetic Kidney Disease: An Update. | Int J Mol Sci | 2023 | 36768457 | PubTator, text mining | PubMed |
| MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. | Int J Mol Sci | 2023 | 36768146 | PubTator, text mining | PubMed |
| Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors. | Mol Med | 2023 | 36747131 | PubTator, text mining | PubMed |
| Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis. | Front Mol Biosci | 2023 | 36726376 | PubTator, text mining | PubMed |
| Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer. | Medicine (Baltimore) | 2023 | 36701720 | PubTator, text mining | PubMed |
| Outside the limit: questioning the distance restrictions for cooperative miRNA binding sites. | Cell Mol Biol Lett | 2023 | 36694129 | PubTator, text mining | PubMed |
| Staphylococcus aureus sequence type (ST) 45, ST30, and ST15 in the gut microbiota of healthy infants - persistence and population counts in relation to ST and virulence gene carriage. | Eur J Clin Microbiol Infect Dis | 2023 | 36689019 | PubTator, text mining | PubMed |
| Effects of Epigallocatechin-3-Gallate on Matrix Metalloproteinases in Terms of Its Anticancer Activity. | Molecules | 2023 | 36677584 | PubTator, text mining | PubMed |
| MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. | Transl Oncol | 2023 | 36608541 | PubTator, text mining | PubMed |
| LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression. | Anticancer Res | 2023 | 36585169 | PubTator, text mining | PubMed |
| Brain endothelial cells acquire blood-brain barrier properties in the absence of Vegf-dependent CNS angiogenesis. | Dev Biol | 2023 | 36502932 | PubTator, text mining | PubMed |
| LIM-domain binding protein 2 was down-regulated by miRNA-96-5p inhibited the proliferation, invasion and metastasis of lung cancer H1299 cells. | Clinics (Sao Paulo) | 2023 | 36473369 | PubTator, text mining | PubMed |
| Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK. | Mol Biotechnol | 2023 | 36454533 | PubTator, text mining | PubMed |
| Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review). | Int J Mol Med | 2023 | 36453246 | PubTator, text mining | PubMed |
| A perspective to weaponize microRNAs against lung cancer. | Noncoding RNA Res | 2023 | 36262424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8434/papers?page=10